全球生命科学
概述
Featured News & Insights
0017
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort
Capabilities
Related Resources
Related Blogs
News & Insights
Sidley & Life Science Cares Reception at BIO 2026Monday, June 22, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 10, 2026
活动
GoodLifeSci
GoodLifeSci
Technology and Life Sciences Transactions
AI Collaborations – From Strategic License to Strategic AcquisitionJune 10, 2026Medtech Advisory Opinion Highlights Scrutiny of Physician Product Line Royalty ArrangementsJune 9, 2026Corporate Practice of Medicine Update: California Attorney General Examines the Friendly Professional Corporation ModelJune 3, 2026DOJ Signals Increasing Scrutiny of Vertically Integrated Healthcare CompaniesJune 3, 2026
Technology and Life Sciences Transactions
Global Life Sciences Update
Healthcare Update
White Collar Defense and Investigations Update
DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 4, 2026Securities Class Actions in the Life Sciences SectorSpring 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessApril 9, 2026FDA's Crackdown On Drug Ads Conflicts With PrecedentApril 2, 2026
Reuters
出版专著
Westlaw Today
Law360
Sidley & Life Science Cares Reception at BIO 2026Monday, June 22, 2026Boston Life Sciences RoundtableTuesday, June 9, 2026Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026
活动
活动
活动
活动
Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026
公告
公告
公告
公告
Sidley Highly Ranked in Chambers USA 2026June 4, 2026Sidley Wins Seven “Firm of the Year” Recognitions at the China Business Law AwardsMay 29, 2026Sidley Wins Three Awards at the Managing IP Americas Awards 2026April 10, 2026Nineteen Sidley Lawyers Named Finalists for the Women in Business Law Americas Awards 2026April 2, 2026
荣誉
荣誉
荣誉
荣誉
AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci









































